Overview

Propofol Versus Midazolam as Premedication for Preterm Neonates With Respiratory Distress Syndrome (RDS)

Status:
Unknown status
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to compare the intubation conditions among propofol and remifentanil versus midazolam and remifentanil in premature neonates with respiratory distress syndrome. At the same time, to show the group of drugs that could let the neonates with no residual sedation after the use of surfactant (the possibility of the premature neonates to be readily extubated after the use of surfactant).
Phase:
Phase 4
Details
Lead Sponsor:
Federal University of Minas Gerais
Treatments:
Midazolam
Propofol